Acta Scientific Ophthalmology (ASOP)

Editorial Volume 4 Issue 1

COVID-19 and Ophthalmology Practice at University Hospital “Policlinico Umberto I” in Rome

Leopoldo Spadea* and Andrea Iannaccone

Eye Clinic, Policlinico “Umberto I”, University “La Sapienza”, Rome, Italy

*Corresponding Author: Leopoldo Spadea, Associate Professor, Head of Eye Clinic, Policlinico “Umberto I”, University “La Sapienza”, Rome, Italy.

Received: November 24, 2020; Published: November 30, 2020


  COVID-19 is a newly defined disease, affecting the respiratory system. It is caused by a novel coronavirus, called Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). The growing importance of the outbreak led the World Health Organization (WHO) to declare it a public health emergency of international concern on 30 January 2020 and to later officially describe it as a pandemic on 11 March 2020 [1]. Italy was the first European country to be heavily impacted by COVID-19, with the number of cases and deaths caused by the virus surging in the months of March and April 2020 [2]. Ophthalmologists represent a high-risk category for the spread of the infection, mainly because the examination demands close contact with the patient, exposing the clinician to tear, conjunctival secretions and to aerosol droplets [3].



  1. Ghebreyesus TA. “WHO Director-General’s opening remarks at the media briefing on COVID-19 – 11”. (2020).
  2. European Centre for Disease Prevention and Control. COVID-19 Situation update worldwide (2020).
  3. Resident physician exposure to novel coronavirus (2019-nCoV, SARS-CoV-2) within New York City during exponential phase of COVID-19 pandemic: Report of the New York City Residency Program Breazzano MP. “Directors COVID-19 Research Group”. medRxiv (2020).
  4. Romano MR., et al. “Facing COVID-19 in ophthalmology department”. Current Eye Research6(2020).
  5. Pirraglia MP., et al. “Retinal involvement and ocular findings in COVID-19 pneumonia patients”. Scientific Report1 (2020): 17419.
  6. Desautels JD., et al. “Risks Posed to Corneal Transplant Recipients by COVID-19-Affected Donors”. Ophthalmology Therapy3 (2020): 371-379.


Citation: Leopoldo Spadea and Andrea Iannaccone. “COVID-19 and Ophthalmology Practice at University Hospital “Policlinico Umberto I” in Rome”. Acta Scientific Ophthalmology 4.1 (2021): 01-02.


Acceptance rate35%
Acceptance to publication20-30 days
ISI- IF1.042
JCR- IF0.24

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US